Creating Hope Reauthorization Act of 2024
118-HR-7384118th CongressIntroduced Feb 15, 2024Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the Subcommittee on Health.
Sponsor
Rep. McCaul, Michael T. [R-TX-10](R-TX-10)66 cosponsors
Summary
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
Subjects
Child healthDrug safety, medical device, and laboratory regulationPrescription drugs
Actions (4)
Referred to the Subcommittee on Health.
Feb 16, 2024House committee actions
Referred to the House Committee on Energy and Commerce.
Feb 15, 2024House floor actions
Introduced in House
Feb 15, 2024Library of Congress
Introduced in House
Feb 15, 2024Library of Congress